Pharmaceutical Strategies Utilizing Recombinant Human Serum Albumin
- 1 May 2002
- journal article
- review article
- Published by Springer Nature in Pharmaceutical Research
- Vol. 19 (5) , 569-577
Abstract
Gene manipulation techniques open up the possibility of making recombinant human serum albumin (rHSA) or mutants with desirable therapeutic properties and for protein fusion products. rHSA can serve...Keywords
This publication has 88 references indexed in Scilit:
- Improvement of hepatorenal syndrome with extracorporeal albumin dialysis mars: Results of a prospective, randomized, controlled clinical trialLiver Transplantation, 2000
- Resistance of the Human Immunodeficiency Virus to the Inhibitory Action of Negatively Charged Albumins on Virus Binding to CD4AIDS Research and Human Retroviruses, 1999
- Blood compatibility of surfaces with immobilized albumin-heparin conjugate and effect of endothelial cell seeding on platelet adhesionJournal of Biomedical Materials Research, 1999
- Anti-HIV-1 Activity of Combinations and Covalent Conjugates of Negatively Charged Human Serum Albumins (NCAs) and AZTJournal of Drug Targeting, 1999
- Physicochemical Properties and O2-Coordination Structure of Human Serum Albumin Incorporating Tetrakis(o-pivalamido)phenylporphyrinatoiron(II) DerivativesBioconjugate Chemistry, 1998
- Recombinant Human Albumin as a Stabilizer for Biological Materials and for the Preparation of International Reference ReagentsBiologicals, 1998
- Effect of Chronic Bile Duct Obstruction and LPS Upon Targeting of Naproxen to the Liver Using Naproxen-Albumin ConjugateJournal of Drug Targeting, 1998
- Mutations in a Specific Human Serum Albumin Thyroxine Binding Site Define the Structural Basis of Familial Dysalbuminemic HyperthyroxinemiaJournal of Biological Chemistry, 1996
- Secretion bySaccharomyces cerevisiaeof Human Apolipoprotein E as a Fusion to Serum AlbuminBioscience, Biotechnology, and Biochemistry, 1995
- Cloning and characterisation of the Saccharomyces cerevisiae glycerol-3-phosphate dehydrogenase (GUT2) promoterGene, 1991